Crossmark

Advanced Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin (GEMCIS) and Novel Inflammatory Markers

Crossref DOI link: https://doi.org/10.1007/s12029-020-00428-6

Published Online: 2020-06-03

Published Print: 2021-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ogul, Ali https://orcid.org/0000-0003-4886-7060
Kidi, Mehmet Mutlu https://orcid.org/0000-0002-4750-720X
Buyuksimsek, Mahmut https://orcid.org/0000-0001-6356-9059
License Information

Text and Data Mining valid from 2020-06-03

Version of Record valid from 2020-06-03
More Information

Article History

First Online: 3 June 2020

Compliance with Ethical Standards

:

: The authors declare that they have no conflict of interest.